or
forgot password

    • cancer clinical trials in great falls, MT

    • Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Sletten Cancer Institute at Benefis Healthcare
    Great Falls, Montana 59405
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Head and Neck Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Benefis Healthcare- Sletten Cancer Institute

    Trial Locations
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Benefis Healthcare- Sletten Cancer Institute

    Trial Locations
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Prostate Cancer
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Berdeaux, Donald MD (UIA Investigator)
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Lymphoma
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Berdeaux, Donald MD (UIA Investigator)
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Breast Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Breast Cancer, Metastatic Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer